Robert J. Hogan

Programming the magnitude and persistence of antibody responses with innate immunity

Sudhir Pai Kasturi, Ioanna Skountzou, Randy A. Albrecht et al. · Nature · 2011 · 959 citations · Full text

Vaccination, Allergy, Autoimmune Disease +11

Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19

Robert L. Hoffman, Robert S. Kania, Mary A. Brothers et al. · Journal of Medicinal Chemistry · 2020 · 518 citations · Full text

Activated Antigen-Specific CD8+ T Cells Persist in the Lungs Following Recovery from Respiratory Virus Infections

Robert J. Hogan, Edward J. Usherwood, Weimin Zhong et al. · The Journal of Immunology · 2001 · 405 citations

Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease

Brendan T. Freitas, Ian A. Durie, Jackelyn Murray et al. · ACS Infectious Diseases · 2020 · 309 citations · Full text

Viral Pathogenesis, Immunology, Molecular Biology +21

Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1

S. Mark Tompkins, Zi-Shan Zhao, Chia-Yun Lo et al. · Emerging infectious diseases · 2007 · 296 citations · Full text